(Q35873691)

10 August 2017

1 reference

title

Pharmacogenetics of dopamine receptors and response to antipsychotic drugs in schizophrenia--an update (English)

1 reference

10 August 2017

0 references

0 references

Joachim Scharfetter

1

1 reference

PubMed ID

15335289

10 August 2017

language of work or name

1 reference

1 September 2004

1 reference

10 August 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Pharmacogenomics

1 reference

10 August 2017

5

1 reference

10 August 2017

6

1 reference

10 August 2017

691-698

1 reference

Dopamine receptor polymorphisms and drug response in schizophrenia

10 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Maternal uniparental disomy 22 has no impact on the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Association study of dopamine D3 receptor gene and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Dopamine D3 receptor gene variants and substance abuse in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Functional polymorphism of -141C Ins/Del in the dopamine D2 receptor gene promoter and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Combination of dopamine D2 receptor gene polymorphisms as a possible predictor of treatment-resistance to dopamine antagonists in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

DRD4 exon III polymorphism and response to risperidone in Israeli adolescents with schizophrenia: a pilot pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

A perspective on molecular genetic studies of tardive dyskinesia: one clue for individualized antipsychotic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Pharmacogenomics in schizophrenia: the quest for individualized therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells express glutamine synthetase: developmental and cell type-specific regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Pharmacogenomics and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Genetic structure of human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakistani patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Dopamine D4 receptor subtypes and response to clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14622416.5.6.691

21 January 2018

Identifiers

DOI

10.1517/14622416.5.6.691

1 reference

10 August 2017

1 reference

PubMed ID

15335289